<DOC>
	<DOC>NCT00160589</DOC>
	<brief_summary>Two weeks study to evaluate the efficacy and safety of Levocetirizine and Desloratadine in patients suffering from Allergic Rhinitis (AR)</brief_summary>
	<brief_title>LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>At least 2year history of Allergic Rhinitis that became symptomatic during the annual grass pollen season. A skin test for grass pollens positive: Have rhinitis symptoms of such severity that the mean T4SS over the baseline period must be 6. Have an associated asthma requiring corticosteroid treatment, Have an atopic dermatitis or an urticaria requiring an antihistamine treatment or the administration of oral or topical corticosteroids,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Allergic Rhinits, Symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), LEADER, Xyzal, Levocetirizine</keyword>
</DOC>